300677:SZSEIntco Medical Technology Co., Ltd. Class A Analysis
Data as of 2026-09-10 - not real-time
CN¥53.79
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At ¥53.79, Intco Medical Technology Co., Ltd. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Across the trailing 30 sessions it gained 7.2%. Momentum indicators put RSI at 56.1 (neutral) with MACD reading bearish. Watch ¥47.05 as support and ¥58.77 as the nearer resistance level.
Valuation screens as undervalued: a P/E of 30.7 sits in line with the sector average of 29.8. Analyst price targets sit 48.7% above the current price. Revenue is growing at 66.2% on a 9.5% profit margin. The 0.37% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 46.9%, a beta of -0.35 and a maximum drawdown of 41.7%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.
Valuation screens as undervalued: a P/E of 30.7 sits in line with the sector average of 29.8. Analyst price targets sit 48.7% above the current price. Revenue is growing at 66.2% on a 9.5% profit margin. The 0.37% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 46.9%, a beta of -0.35 and a maximum drawdown of 41.7%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.
Top Market Events
Investing5monShandong Intco Medical Products Co LtdThe 1 year price total return measures the total change in price...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 47.18
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 30.7 versus sector average of 29.8
- Trading above the 200-day average of 47.18
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 30.7 versus sector average of 29.8
- Analyst targets imply +48.7% versus the current price
- Revenue growth of +66.2%
Key Metrics & Analysis
Financial Health
Revenue Growth66.20%
Profit Margin9.54%
P/E Ratio30.7
ROE6.50%
ROA3.35%
Debt/Equity90.16
P/B Ratio2.2
Op. Cash FlowCN¥2.9B
Free Cash FlowCN¥378.6M
Industry P/E29.8
Technical Analysis
TrendBullish
RSI56.1
SupportCN¥47.05
ResistanceCN¥58.77
MA 20CN¥52.23
MA 50CN¥49.07
MA 200CN¥47.18
MACDBearish
VolumeStable
Fear & Greed Index92.04
Valuation
Fair ValueCN¥16.28
Target PriceCN¥80.00
Upside/Downside48.73%
GradeUndervalued
TypeGrowth
Dividend Yield0.37%
Risk Assessment
Beta-0.35
Volatility46.90%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.